Baker Tilly Wealth Management LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 11.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,211 shares of the healthcare conglomerate’s stock after selling 153 shares during the quarter. Baker Tilly Wealth Management LLC’s holdings in UnitedHealth Group were worth $613,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Kathleen S. Wright Associates Inc. purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at $27,000. Global Wealth Strategies & Associates boosted its stake in shares of UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the period. West Financial Advisors LLC bought a new stake in UnitedHealth Group during the 3rd quarter valued at approximately $32,000. Quarry LP raised its position in shares of UnitedHealth Group by 132.1% during the second quarter. Quarry LP now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 37 shares during the last quarter. Finally, VitalStone Financial LLC boosted its position in shares of UnitedHealth Group by 600.0% during the second quarter. VitalStone Financial LLC now owns 70 shares of the healthcare conglomerate’s stock worth $36,000 after acquiring an additional 60 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have commented on UNH. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Cantor Fitzgerald lifted their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. Finally, Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $626.79.
UnitedHealth Group Trading Up 0.7 %
Shares of NYSE:UNH traded up $3.48 during trading on Friday, reaching $528.00. 1,571,818 shares of the company were exchanged, compared to its average volume of 3,514,637. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a market capitalization of $485.91 billion, a PE ratio of 34.40, a P/E/G ratio of 1.53 and a beta of 0.62. The business’s fifty day simple moving average is $556.20 and its 200-day simple moving average is $561.20. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH – Get Free Report) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the business earned $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is a SEC Filing?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What is the Euro STOXX 50 Index?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
- How to Buy Cheap Stocks Step by Step
- 3 EV Stocks Offering Unique Alternatives to Tesla
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.